The ownership structure of Cytokinetics (CYTK) stock is a mix of institutional, retail and individual investors. Approximately 58.59% of the company’s stock is owned by Institutional Investors, 17.02% is owned by Insiders and 24.39% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Apr 09, 2024	Fady Ibraham Malik Evp Research & Development	Sold	$2422918
Dec 01, 2023	Robert Blum President & Ceo,director	Sold	$412375
Nov 15, 2023	Robert Blum President & Ceo,director	Sold	$432125
Nov 09, 2023	Fady Ibraham Malik Evp Research & Development	Sold	$88500

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Fortitude Family Office, Llc	Bought	$1252
Dec 31, 2023	Deerfield Management Company, Lp	Bought	$264162
Dec 31, 2023	Moore Capital Management Lp	Sold	$417450
Dec 31, 2023	Platinum Investment Management	Bought	$1597831

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
9,479,371	Institution	9.06%	654,076,599
8,514,702	Institution	8.14%	587,514,438
8,080,158	Institution	7.73%	557,530,902
2,700,971	Institution	2.58%	186,366,999
2,685,483	Institution	2.57%	185,298,327
2,633,619	Institution	2.52%	181,719,711
1,896,313	Institution	1.81%	130,845,597
1,805,171	Institution	1.73%	124,556,799
1,666,102	Institution	1.59%	114,961,038
1,469,555	Institution	1.41%	101,399,295

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
8,514,702	Institution	8.14%	587,514,438
2,700,971	Institution	2.58%	186,366,999
2,633,619	Institution	2.52%	181,719,711
1,896,313	Institution	1.81%	130,845,597
1,805,171	Institution	1.73%	124,556,799
1,666,102	Institution	1.59%	114,961,038
1,469,555	Institution	1.41%	101,399,295
1,158,215	Institution	1.11%	79,916,835
1,038,243	Institution	0.99%	71,638,767
996,039	Institution	0.95%	68,726,691

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	3,104,142	Institution	2.97%	217,631,396
iShares Core S&P Mid-Cap ETF	3,051,025	Institution	2.92%	210,520,725
Vanguard Small-Cap ETF	2,500,993	Institution	2.39%	175,344,619
iShares Russell 2000 ETF	2,286,449	Institution	2.19%	157,764,981
Vanguard Extended Market ETF	1,468,843	Institution	1.40%	102,980,583
Vanguard Small-Cap Growth ETF	1,415,960	Institution	1.35%	99,272,956
SPDR S&P BIOTECH ETF	1,115,595	Institution	1.07%	75,860,460
SPDR S&P Midcap 400 ETF Trust	797,524	Institution	0.76%	55,029,156
iShares Russell 2000 Growth ETF	763,063	Institution	0.73%	52,651,347
iShares Biotechnology ETF	745,026	Institution	0.71%	51,406,794

FAQ

Who Owns Cytokinetics (CYTK)?

According to the latest TipRanks data, approximately 20.64% of the company's stock is held by institutional investors, 17.02% is held by insiders, and 24.39% is held by retail investors.

What percentage of Cytokinetics (CYTK) stock is held by institutional investors?

According to the latest TipRanks data, approximately 20.64% of Cytokinetics (CYTK) stock is held by institutional investors.

What percentage of Cytokinetics (CYTK) stock is held by retail investors?

According to the latest TipRanks data, approximately 24.39% of Cytokinetics (CYTK) stock is held by retail investors.

Who owns the most shares of Cytokinetics (CYTK)?

Vanguard owns the most shares of Cytokinetics (CYTK).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing